Text Size:   A+ A- A   •   Text Only
Site Image

DHS news release

March 23, 2005


Contact: Bonnie Widerburg (971) 673-1282
Technical contact: Dave Stone (971) 673-0444

Public meeting notice

Biopharming Ad Hoc Committee meets March 27 in Portland

What: Biopharming Ad Hoc Committee meeting.


When: Monday from 1 p.m. to 3 p.m.

Where: Room 918, Portland State Office Building, 800 N.E. Oregon Street, Portland

Agenda: Discussion of administrative issues, followed by technical presentations on state authorities and journal articles. Daniel Goldstein, M.D., Monsanto, and Doug Gurian-Sherman, Ph.D., with the Center for Food Safety, will discuss human health risks and benefits related to biopharmaceuticals.


Background: The governor and the 2005 Senate charged the Oregon departments of Agriculture and Human Services with convening a Biopharming Ad Hoc committee to develop a consensus policy recommendation to the governor regarding biopharmaceuticals produced in human food or animal feed crops.

Biopharming is the production of pharmaceutical proteins or other materials in genetically engineered plants and animals.

The Committee has 10 standing members and is chaired by Jim Rue, State Board of Agriculture, with Keith Harcourt, Public Health Advisory Board, serving as vice-chair. The State Board of Agriculture and the Public Health Advisory Board are equally represented, along with two independent scientists and two non-voting ex-officio members representing the Oregon Department of Agriculture and Department of Human Services.

Future meetings will be held monthly, with the location of meetings to alternate between Portland and Salem.